Home > Publications database > Comment on: β Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies (Zhong et al., 2015; published Epub ahead of print 3 September 2015). > print

001     141122
005     20240229105119.0
024 7 _ |a 10.1097/CEJ.0000000000000243
|2 doi
024 7 _ |a pmid:29369941
|2 pmid
024 7 _ |a 0959-8278
|2 ISSN
024 7 _ |a 1473-5709
|2 ISSN
037 _ _ |a DKFZ-2018-01656
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Weberpals, Janick
|0 P:(DE-He78)bf5409aed74a0923d9402c2c7ad620aa
|b 0
|e First author
|u dkfz
245 _ _ |a Comment on: β Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies (Zhong et al., 2015; published Epub ahead of print 3 September 2015).
260 _ _ |a Philadelphia, Pa. [u.a.]
|c 2018
|b Lippincott Williams & Wilkins
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1540555445_23501
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Adrenergic beta-Antagonists
|2 NLM Chemicals
700 1 _ |a Carr, Prudence
|0 P:(DE-He78)7d7ee36ed0313bbc4c91bc3df5950107
|b 1
|u dkfz
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 2
|u dkfz
700 1 _ |a Jansen, Lina
|0 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09
|b 3
|e Last author
|u dkfz
773 _ _ |a 10.1097/CEJ.0000000000000243
|g Vol. 27, no. 1, p. 103 - 104
|0 PERI:(DE-600)2025799-5
|n 1
|p 103 - 104
|t European journal of cancer prevention
|v 27
|y 2018
|x 0959-8278
909 C O |o oai:inrepo02.dkfz.de:141122
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)bf5409aed74a0923d9402c2c7ad620aa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)7d7ee36ed0313bbc4c91bc3df5950107
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J CANCER PREV : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l Klinische Epidemiologie und Alternsforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21